Chiara Cremolini, Paolo Ciracì, Filippo Pietrantonio, Sara Lonardi, Marco Maria Germani, Adele Busico, Paolo Manca, Gianmarco Ricagno, Nicoletta Pella, Vincenzo Formica, Mario Scartozzi, Valentina Burgio, Samantha Di Donato, Roberto Moretto, Iolanda Capone, Federica Palermo, Federica Marmorino, Gianluca Masi, Luca Boni, Daniele Rossini. "Panitumumab retreatment followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with
            <i>RAS</i>
            and
            <i>BRAF</i>
            wild-type circulating tumor DNA (ctDNA): Results of the phase II randomized PARERE trial by GONO.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.17_suppl.lba3515